Provisions for the Pharmaceutical Services Committee of Inquiry are under the National Health Act 1953. The Act allows a Committee to be established at either a state or federal level. The current Federal level committee was established in 2015 to investigate matters of suspected non-compliance with a pharmacist's approval to supply Pharmaceutical Benefits Scheme (PBS) medicines, including the conditions of approval. In particular, where PBS medicines are being supplied at premises for which the pharmacist is not approved. The Act specifies the membership of the Committee consists of four pharmacists appointed by the Minister for Health and Aged Care as well as the Secretary of the Department of Health and Aged Care (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).
Further information
-
Type of Body
E. Statutory office holder, offices and committees
-
Established By / Under
Act / Regulation
-
Established By/Under More info
National Health Act 1953
-
Paid Members?
Yes
-
Max No. of Board/Committee Members
5
-
Annual Report Prepared and tabled?
No
-
Classification
B. Secondary statutory structure
-
Function Categorization
Regulatory / Review / Inquiry / Commission
-
Creation Date
Current board appointments
| Position | Appointee | Start Date | End Date |
|---|---|---|---|
| Chair | Ms. Renae Beardmore | 20 April 2021 | 20 April 2099 |
| Member | Dr. Helen Benson | 22 April 2024 | 22 April 2099 |
| Member | Helen Toyne | 1 December 2024 | 1 June 2025 |
| Member | Ms Ms. Juliana Sestan | 20 April 2021 | Determined by the appointer |
| Member | Ms. Helen Dowling | 20 April 2021 | Determined by the appointer |
Last updated: